Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, single-arm, open-label study to evaluate the safety, PK, and tolerability
of a repeated (3 times weekly) dose of difelikefalin administered as IV bolus injections to
adult Chinese HD subjects. Treatment period is one week and there is a safety follow-up
period of 1 week.